UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 149

Sortiert nach

Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission

Blood, 2010-10, Vol.116 (17), p.3157-3162

2010

Volltextzugriff (PDF)

Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group

Haematologica (Roma), 2010-09, Vol.95 (9), p.1489-1495

2010

Volltextzugriff (PDF)

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

The New England journal of medicine, 2008-08, Vol.359 (9), p.906-917

2008

Volltextzugriff (PDF)

Genetically identical twin transplantation for chronic lymphocytic leukemia

Leukemia, 2007-12, Vol.21 (12), p.2452-2455

2007

Volltextzugriff (PDF)

Stem cell transplantation in ALL : a donor versus no donor comparison in the EORTC ALL-4 study

2007-09

Volltextzugriff (PDF)

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61 70 years: results of the prospective EORTC GIMEMA AML 13 study

Haematologica (Roma), 2007-03, Vol.92 (3), p.389-396

2007

Volltextzugriff (PDF)

E07 Stem cell transplantation in ALL: a donor versus no donor comparison in the EORTC ALL-4 study

Leukemia research, 2007, Vol.31, p.S15-S16

2007

Volltextzugriff (PDF)

O07 Dexamethasone versus methyl-prednisolone for adult acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL) in patients ≤60 yrs old: final results of the EORTC ALL-4 Phase III Trial

Blood reviews, 2007, Vol.21, p.S69-S69

2007

Volltextzugriff (PDF)

Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2465-2471

2006

Volltextzugriff (PDF)

Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission

Clinical transplantation, 2006-03, Vol.20 (2), p.179-187

2006

Volltextzugriff (PDF)

Allogeneic transplantation for adult acute lymphoblastic leukemia: Intention to treat analysis of the EORTC ALL-4 phase III trial

Biology of blood and marrow transplantation, 2006-02, Vol.12 (2), p.6-7

2006

Volltextzugriff (PDF)

Long-term remission with surgery for recurrent localized Hodgkin lymphoma

The Journal of thoracic and cardiovascular surgery, 2005-05, Vol.129 (5), p.1172-1172

2005

Volltextzugriff (PDF)

Long-term remission with surgery for recurrent localized Hodgkin lymphoma. Dicussion

The Journal of thoracic and cardiovascular surgery, 2005, Vol.129 (5)

2005

Volltextzugriff (PDF)

Long Term Follow-Up Shows No Clinical Benefit for CD34+ Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study

BLOOD, 2004-11, Vol.104 (11), p.921-921

2004

Volltextzugriff (PDF)

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

Annals of the rheumatic diseases, 2004-08, Vol.63 (8), p.974-981

2004

Volltextzugriff (PDF)

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial

Haematologica (Roma), 2004-07, Vol.89 (7), p.809

2004

Volltextzugriff (PDF)

Probable rofecoxib‐induced thrombocytopenia

Rheumatology (Oxford, England), 2003-05, Vol.42 (5), p.699-700

2003

Volltextzugriff (PDF)

Atypical recurrent varicella in 4 patients with hemopathies

Journal of the American Academy of Dermatology, 2003-03, Vol.48 (3), p.442-447

2003

Volltextzugriff (PDF)

Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts

Leukemia, 2003-02, Vol.17 (2), p.319-322

2003

Volltextzugriff (PDF)

CD34(+) selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma shows no significant clinical benefit at 4 years: An EBMT phase III randomized study

BLOOD, 2003, Vol.102 (11), p.988A

2003

Volltextzugriff (PDF)

Renaissance of thalidomide

Revue médicale de Bruxelles, 2002-12, Vol.23 (6), p.504

2002

Volltextzugriff (PDF)

High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier

Bone marrow transplantation (Basingstoke), 2002-02, Vol.29 (3), p.273-275

2002

Volltextzugriff (PDF)

The hematology clinic

Revue médicale de Bruxelles, 2002, Vol.23 Suppl 2, p.77

2002

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(110)
Male
(58)
Female
(56)
Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Middle Aged
(51)
Adult
(46)
Aged
(41)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Hematology
(27)
Hematologic And Hematopoietic Diseases
(17)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(15)
Oncology
(13)
Adolescent
(11)
Prognosis
(11)
Disease-Free Survival
(10)
Aids/hiv
(8)
Immunopathology
(8)
Treatment Outcome
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission

Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Genetically identical twin transplantation for chronic lymphocytic leukemia

Stem cell transplantation in ALL : a donor versus no donor comparison in the EORTC ALL-4 study

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61 70 years: results of the prospective EORTC GIMEMA AML 13 study

E07 Stem cell transplantation in ALL: a donor versus no donor comparison in the EORTC ALL-4 study

O07 Dexamethasone versus methyl-prednisolone for adult acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL) in patients ≤60 yrs old: final results of the EORTC ALL-4 Phase III Trial

Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission

Allogeneic transplantation for adult acute lymphoblastic leukemia: Intention to treat analysis of the EORTC ALL-4 phase III trial

Long-term remission with surgery for recurrent localized Hodgkin lymphoma

Long-term remission with surgery for recurrent localized Hodgkin lymphoma. Dicussion

Long Term Follow-Up Shows No Clinical Benefit for CD34+ Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial

Probable rofecoxib‐induced thrombocytopenia

Atypical recurrent varicella in 4 patients with hemopathies

Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts

CD34(+) selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma shows no significant clinical benefit at 4 years: An EBMT phase III randomized study

Renaissance of thalidomide

High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier

The hematology clinic

Suchergebnisse filtern